ABBV : AbbVie stock forecast, predictions, and share price target for 2022, 2023 (1 year) to 2025 - 2027 (5 year) to 2030, and 2032 (10 year) with Revenue and EPS Prognosis by Technical Analysis
| year | Average | Low | High | Change from close on 2022-08-12 |
|---|---|---|---|---|
| 2022 | $141.69 | $140.75 | $142.33 | -0.64% |
| 2023 | $133.57 | $128.78 | $139.79 | -6.33% |
| 2024 | $124.55 | $118.57 | $128.42 | -12.66% |
| 2025 | $112.4 | $108.13 | $117.29 | -21.18% |
| 2026 | $102.75 | $99.55 | $107.21 | -27.95% |
| 2027 | $98.55 | $98.17 | $99.28 | -30.89% |
| 2028 | $98.91 | $98.57 | $98.97 | -30.64% |
| 2029 | $99.01 | $98.93 | $99.19 | -30.57% |
| 2030 | $109.14 | $99.28 | $140.5 | -23.47% |
| 2031 | $174.35 | $152.43 | $180.43 | 22.26% |
| 2032 | $172.54 | $170.2 | $175.18 | 21.0% |
The 9 Wall Street analysts offering AbbVie stock forecast in the last 6 months have average price target of
$171.78 with a high forecast of $200.0 and a low forecast of $140.0.
The average AbbVie stock forecast represents a 20.46%
increase from the last price of $142.600006103516.
From AI system, total return is 3178.18% from 3810 forecasts.
For AbbVie stock forecast for 2022, 4 predictions are offered for each month of 2022 with average AbbVie stock
forecast of $141.69, a high forecast of $142.33, and a low forecast of $140.75.
The average AbbVie stock forecast 2022 represents a -0.64%
decrease from the last price of $142.600006103516.
For AbbVie stock forecast for 2023, 12 predictions are offered for each month of 2023 with average AbbVie stock
forecast of $133.57, a high forecast of $139.79, and a low forecast of $128.78.
The average AbbVie stock forecast 2023 represents a -6.33%
decrease from the last price of $142.600006103516.
For AbbVie stock forecast for 2025, 12 predictions are offered for each month of 2025 with average AbbVie stock
forecast of $112.4, a high forecast of $117.29, and a low forecast of $108.13.
The average AbbVie stock forecast 2025 represents a -21.18%
decrease from the last price of $142.600006103516.
For AbbVie stock forecast for 2027 (5 year), 12 predictions are offered for each month of 2027 with average AbbVie stock
forecast of $98.55, a high forecast of $99.28, and a low forecast of $98.17.
The average AbbVie stock forecast 2027 represents a -30.89%
decrease from the last price of $142.600006103516.
For AbbVie stock forecast for 2030, 12 predictions are offered for each month of 2030 with average AbbVie stock
forecast of $109.14, a high forecast of $140.5, and a low forecast of $99.28.
The average AbbVie stock forecast 2030 represents a -23.47%
decrease from the last price of $142.600006103516.
For AbbVie stock forecast for 2032 (10 year), 8 predictions are offered for each month of 2032 with average AbbVie stock
forecast of $172.54, a high forecast of $175.18, and a low forecast of $170.2.
The average AbbVie stock forecast 2032 represents a 21.0%
increase from the last price of $142.600006103516.
Please, see more forecasts below.
ABBV : AbbVie stock forecast by Wall Street Analysts
The average AbbVie stock forecast from last 6 month is $171.78, and this show a 12.57% increase in average from the prior price target of the each prediction. Also, this average forecast of $171.78 represents a 19.23% increase from the past average forecast of $144.08, 6 months ago from 13 wall street analysts.
AbbVie stock forecast for upcoming days
| Date | Price Target | Change |
|---|---|---|
| 2022-08-15 | $142.32 | -0.20% |
| 2022-08-16 | $141.93 | -0.27% |
| 2022-08-17 | $142.26 | 0.23% |
| 2022-08-18 | $144.21 | 1.37% |
| 2022-08-19 | $145.75 | 1.07% |
ABBV : Long term AbbVie stock forecast for 2022, 2023 (1 year) - 2025 - 2027 (5 year) - 2030, and 2032 (10 year)
Forecast for 2022 Sep. is $142.33 , for 2023 Aug. is $131.38 , for 2026 Aug. is $101.25 , for 2027 Aug. is $98.32 , for 2031 Aug. is $179.26 , and for 2032 Aug. is $170.20.
ABBV : AbbVie stock forecast for 2022
| Date | Price Target | Change |
|---|---|---|
| 2022 Sep. | $142.33 | -0.19% |
| 2022 Oct. | $142.14 | -0.13% |
| 2022 Nov. | $141.53 | -0.43% |
| 2022 Dec. | $140.75 | -0.55% |
ABBV : AbbVie stock forecast for 2023
| Date | Price Target | Change |
|---|---|---|
| 2023 Jan. | $139.79 | -0.69% |
| 2023 Feb. | $138.67 | -0.80% |
| 2023 Mar. | $137.34 | -0.96% |
| 2023 Apr. | $136.00 | -0.98% |
| 2023 May. | $134.52 | -1.09% |
| 2023 Jun. | $133.24 | -0.95% |
| 2023 Jul. | $132.49 | -0.56% |
| 2023 Aug. | $131.38 | -0.84% |
| 2023 Sep. | $129.88 | -1.14% |
| 2023 Oct. | $131.27 | 1.07% |
| 2023 Nov. | $129.53 | -1.32% |
| 2023 Dec. | $128.78 | -0.58% |
ABBV : AbbVie stock forecast for 2024
| Date | Price Target | Change |
|---|---|---|
| 2024 Jan. | $128.42 | -0.28% |
| 2024 Feb. | $128.07 | -0.27% |
| 2024 Mar. | $127.67 | -0.31% |
| 2024 Apr. | $127.17 | -0.39% |
| 2024 May. | $126.54 | -0.49% |
| 2024 Jun. | $125.79 | -0.60% |
| 2024 Jul. | $124.84 | -0.75% |
| 2024 Aug. | $123.77 | -0.86% |
| 2024 Sep. | $122.57 | -0.97% |
| 2024 Oct. | $121.25 | -1.08% |
| 2024 Nov. | $119.91 | -1.11% |
| 2024 Dec. | $118.57 | -1.12% |
ABBV : AbbVie stock forecast for 2025
| Date | Price Target | Change |
|---|---|---|
| 2025 Jan. | $117.29 | -1.08% |
| 2025 Feb. | $116.09 | -1.02% |
| 2025 Mar. | $114.99 | -0.94% |
| 2025 Apr. | $114.06 | -0.81% |
| 2025 May. | $113.24 | -0.72% |
| 2025 Jun. | $112.51 | -0.65% |
| 2025 Jul. | $111.87 | -0.57% |
| 2025 Aug. | $111.23 | -0.58% |
| 2025 Sep. | $110.55 | -0.60% |
| 2025 Oct. | $109.82 | -0.66% |
| 2025 Nov. | $109.01 | -0.74% |
| 2025 Dec. | $108.13 | -0.81% |
ABBV : AbbVie stock forecast for 2026
| Date | Price Target | Change |
|---|---|---|
| 2026 Jan. | $107.21 | -0.85% |
| 2026 Feb. | $106.31 | -0.84% |
| 2026 Mar. | $105.40 | -0.86% |
| 2026 Apr. | $104.41 | -0.94% |
| 2026 May. | $103.48 | -0.89% |
| 2026 Jun. | $102.64 | -0.81% |
| 2026 Jul. | $101.89 | -0.73% |
| 2026 Aug. | $101.25 | -0.63% |
| 2026 Sep. | $100.71 | -0.54% |
| 2026 Oct. | $100.25 | -0.45% |
| 2026 Nov. | $99.87 | -0.38% |
| 2026 Dec. | $99.55 | -0.32% |
ABBV : AbbVie stock forecast for 2027
| Date | Price Target | Change |
|---|---|---|
| 2027 Jan. | $99.28 | -0.27% |
| 2027 Feb. | $99.06 | -0.22% |
| 2027 Mar. | $98.88 | -0.19% |
| 2027 Apr. | $98.73 | -0.15% |
| 2027 May. | $98.60 | -0.13% |
| 2027 Jun. | $98.49 | -0.11% |
| 2027 Jul. | $98.39 | -0.09% |
| 2027 Aug. | $98.32 | -0.08% |
| 2027 Sep. | $98.25 | -0.07% |
| 2027 Oct. | $98.20 | -0.05% |
| 2027 Nov. | $98.17 | -0.03% |
| 2027 Dec. | $98.22 | 0.05% |
ABBV : AbbVie stock forecast for 2028
| Date | Price Target | Change |
|---|---|---|
| 2028 Jan. | $98.57 | 0.35% |
| 2028 Feb. | $98.85 | 0.28% |
| 2028 Mar. | $98.88 | 0.03% |
| 2028 Apr. | $98.90 | 0.02% |
| 2028 May. | $98.93 | 0.03% |
| 2028 Jun. | $98.95 | 0.02% |
| 2028 Jul. | $98.97 | 0.01% |
| 2028 Aug. | $98.97 | 0.01% |
| 2028 Sep. | $98.97 | -0.00% |
| 2028 Oct. | $98.97 | -0.01% |
| 2028 Nov. | $98.96 | -0.01% |
| 2028 Dec. | $98.95 | -0.01% |
ABBV : AbbVie stock forecast for 2029
| Date | Price Target | Change |
|---|---|---|
| 2029 Jan. | $98.94 | -0.01% |
| 2029 Feb. | $98.93 | -0.00% |
| 2029 Mar. | $98.94 | 0.00% |
| 2029 Apr. | $98.94 | 0.01% |
| 2029 May. | $98.95 | 0.01% |
| 2029 Jun. | $98.96 | 0.01% |
| 2029 Jul. | $98.98 | 0.02% |
| 2029 Aug. | $99.01 | 0.02% |
| 2029 Sep. | $99.04 | 0.03% |
| 2029 Oct. | $99.07 | 0.04% |
| 2029 Nov. | $99.12 | 0.05% |
| 2029 Dec. | $99.19 | 0.07% |
ABBV : AbbVie stock forecast for 2030
| Date | Price Target | Change |
|---|---|---|
| 2030 Jan. | $99.28 | 0.09% |
| 2030 Feb. | $99.41 | 0.13% |
| 2030 Mar. | $99.62 | 0.21% |
| 2030 Apr. | $99.96 | 0.34% |
| 2030 May. | $100.53 | 0.58% |
| 2030 Jun. | $101.54 | 1.01% |
| 2030 Jul. | $103.33 | 1.76% |
| 2030 Aug. | $106.39 | 2.96% |
| 2030 Sep. | $111.35 | 4.67% |
| 2030 Oct. | $118.85 | 6.73% |
| 2030 Nov. | $128.87 | 8.44% |
| 2030 Dec. | $140.50 | 9.02% |
ABBV : AbbVie stock forecast for 2031
| Date | Price Target | Change |
|---|---|---|
| 2031 Jan. | $152.43 | 8.49% |
| 2031 Feb. | $163.07 | 6.98% |
| 2031 Mar. | $171.34 | 5.07% |
| 2031 Apr. | $176.80 | 3.19% |
| 2031 May. | $179.62 | 1.59% |
| 2031 Jun. | $180.43 | 0.45% |
| 2031 Jul. | $180.07 | -0.20% |
| 2031 Aug. | $179.26 | -0.45% |
| 2031 Sep. | $178.42 | -0.47% |
| 2031 Oct. | $177.67 | -0.42% |
| 2031 Nov. | $176.95 | -0.41% |
| 2031 Dec. | $176.12 | -0.46% |
ABBV : AbbVie stock forecast for 2032
| Date | Price Target | Change |
|---|---|---|
| 2032 Jan. | $175.18 | -0.53% |
| 2032 Feb. | $174.15 | -0.59% |
| 2032 Mar. | $173.21 | -0.54% |
| 2032 Apr. | $172.57 | -0.37% |
| 2032 May. | $172.17 | -0.23% |
| 2032 Jun. | $171.74 | -0.25% |
| 2032 Jul. | $171.12 | -0.37% |
| 2032 Aug. | $170.20 | -0.54% |
Financial Data for AbbVie stock
Frequently Asked Questions about AbbVie stock forecast
Is AbbVie a good long term stock?
From AbbVie stock forecast , AbbVie (ABBV) stock cannot be a good investment choice. According to AI Pickup, the AbbVie stock price forecast for 2022 Sep. is $142.325595078357 From AbbVie stock forecast , AbbVie (ABBV) stock cannot be a good investment choice. According to AI Pickup, the AbbVie stock price forecast for 2023 Aug. is $131.3774188224 From AbbVie stock forecast , AbbVie (ABBV) stock cannot be a good investment choice. According to AI Pickup, the AbbVie stock price forecast for 2026 Aug. is $101.250113240106 From AbbVie stock forecast , AbbVie (ABBV) stock cannot be a good investment choice. According to AI Pickup, the AbbVie stock price forecast for 2027 Aug. is $98.3163269592562 From AbbVie stock forecast , AbbVie (ABBV) stock can be a good investment choice. According to AI Pickup, the AbbVie stock price forecast for 2031 Aug. is $179.262335292075 From AbbVie stock forecast , AbbVie (ABBV) stock can be a good investment choice. According to AI Pickup, the AbbVie stock price forecast for 2032 Aug. is $170.197809106513
Is AbbVie stock overvalued?
AbbVie (ABBV) stock is expected to go DOWN . Therefore, AI Pickup would say that AbbVie (ABBV) stock is overvalued.
Will AbbVie stock price go up?
No. The AbbVie stock price forecast for 2023 Aug. is $131.3774188224
Is AbbVie stock a good buy now?
Since closing price on 2022-08-12 is $142.600006103516 and forecast for 2023 Aug. is $131.38, AbbVie stock is not a good 1 year investment.